Ads
related to: hyperphosphatemia treatment guidelines chart- Dosing & Administration
Phosphate Control With Flexible
Dosing For Patients On Dialysis.
- Phosphate Binder Info
Phosphate Binder For Dialysis
Patients With Hyperphosphatemia.
- Watch An MOA Video
Phosphate Binder Potency Info
For Your Patients.
- Access Information
Visit To Find Access Information
For A Hyperphosphatemia Treatment.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood. [1] Most people have no symptoms while others develop calcium deposits in the soft tissue. [1] The disorder is often accompanied by low calcium blood levels, which can result in muscle spasms. [1]
There have been limited trials comparing phosphate binders to placebo in the treatment of hyperphosphatemia in people with chronic kidney disease. When compared with people receiving calcium-based binders, people taking sevelamer have a reduced all-cause mortality. [4]
Sevelamer is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals.
[1] [2] The causes, severity, treatment, and outcomes of these disturbances can differ greatly depending on the implicated electrolyte. [3] The most serious electrolyte disturbances involve abnormalities in the levels of sodium, potassium or calcium. Other electrolyte imbalances are less common and often occur in conjunction with major ...
{{Drugs for treatment of hyperkalemia and hyperphosphatemia | state = collapsed}} will show the template collapsed, i.e. hidden apart from its title bar. {{Drugs for treatment of hyperkalemia and hyperphosphatemia | state = expanded}} will show the template expanded, i.e. fully visible.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Ads
related to: hyperphosphatemia treatment guidelines chart